At the Psychologist
Screen Shot 2021-04-01 at 8.19.46 PM.png

PsyBio Therapeutics Augments Intellectual Property Portfolio

an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically...

At the Psychologist
Screen Shot 2021-04-01 at 8.19.46 PM.png

BIONTECH, PSYBIO, BAYER: THE OPPORTUNITIES OF TOMORROW

BioNTech's vaccine could be a constant companion for people in the future...

At the Psychologist
Screen Shot 2021-04-01 at 8.19.46 PM.png

PsyBio CEO to Present at Two Virtual Investor Conferences in June

OXFORD, Ohio and COCONUT CREEK, Fla., June 3, 2021 /PRNewswire/ -- PsyBio Therapeutics Corp. ..

At the Psychologist

Curevac, Psybio, Evotec- revolution in the Billion...

The anxiety and limitations associated with the coronavirus pose major....

At the Psychologist
Screen Shot 2021-04-01 at 8.19.46 PM.png

PsyBio Therapeutics Reports First Quarter 2021 Financial Results

OXFORD, Ohio and COCONUT CREEK, Fla., June 1, 2021 /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTC: PSYBF)...

At the Psychologist

Genetic Engineering & Biotechnology
News

Psilocybin mushrooms make tryptamines, which are responsible for their hallucinogenic effects, but also can be used...